These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13514035)

  • 1. Deficiencies in the lipoprotein lipase system in atherosclerosis.
    PILGERAM LO
    J Gerontol; 1958 Jan; 13(1):32-42. PubMed ID: 13514035
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on correlations between plasmatic clearing activity and lipoprotein dispersion in atherosclerosis].
    JANNI A; LAURA A
    Riforma Med; 1961 Nov; 75():1301-5. PubMed ID: 14451163
    [No Abstract]   [Full Text] [Related]  

  • 3. New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis.
    Beisiegel U
    Atherosclerosis; 1996 Jul; 124(1):1-8. PubMed ID: 8800489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On heparin in the blood and clearing factor in atherosclerosis].
    LIPOVETSKII BM
    Ter Arkh; 1962 Mar; 34():46-52. PubMed ID: 14465712
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis and lipoprotein lipase activation capacity of plasma lipoproteins isolated from atherosclerosis-susceptible White Carneau pigeon and atherosclerosis-resistant Show Racer pigeon.
    Hogg SI; Cryer A
    Comp Biochem Physiol B; 1984; 79(2):251-4. PubMed ID: 6509917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 5: Normolipidemic (latent) dyslipoproteinemia.
    Choluj B
    Acta Univ Carol Med (Praha); 1991; 37(3-4):141-55. PubMed ID: 1845468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein lipase in the blood in obliterating atherosclerosis].
    ZMUDZINSKI J; ZMUDZINSKA M
    Pol Arch Med Wewn; 1961; 31():61-6. PubMed ID: 13788697
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.
    Shimada M; Ishibashi S; Inaba T; Yagyu H; Harada K; Osuga JI; Ohashi K; Yazaki Y; Yamada N
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7242-6. PubMed ID: 8692976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearing factor inhibitor in human atherosclerosis.
    DAY AJ; WILKINSON GN
    Circulation; 1958 Jul; 18(1):76-81. PubMed ID: 13547388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Critical study of variations of various blood lipids in the arteriosclerotic patient].
    DELCOURT R
    Acta Cardiol; 1961; 16():414-24. PubMed ID: 13721536
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the lipolytic activity of blood serum in atherosclerosis.
    CISWICKA M; MICHAJLIK A; SZNAJDERMAN M
    Acta Med Scand; 1958 Jul; 161(5):391-5. PubMed ID: 13559011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood lipoprotein lipase activity in arteriosclerosis].
    SZCZEKLIK E; LUKASIK S; ORLOWSKI M
    Pol Tyg Lek (Wars); 1959 Feb; 14(7):297-300. PubMed ID: 13667562
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clearing factor in normal subjects, in arteriosclerotic patients, in the aged and in diabetics].
    MOSSO HE; KATZ S; PERGOLA F
    Prensa Med Argent; 1961 Jul; 48():2035-40. PubMed ID: 14476560
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research on the enzymes of human blood. IV. Definition of a lipase in human serum (CE), its relation to the clearing factor (lipoprotein lipase) and its routine determination].
    HOERLEIN H; PILZ W
    Hoppe Seylers Z Physiol Chem; 1962 May; 327():256-73. PubMed ID: 13908035
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK; Pasternack A; Vänttinen T; Ehnholm C; Nikkilä EA
    Acta Med Scand; 1978; 204(3):211-8. PubMed ID: 211802
    [No Abstract]   [Full Text] [Related]  

  • 16. Postheparin plasma triglyceride lipases in chronic hemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism.
    Applebaum-Bowden D; Goldberg AP; Hazzard WR; Sherrard DJ; Brunzell JD; Huttunen JK; Nikkila EA; Ehnholm C
    Metabolism; 1979 Sep; 28(9):917-24. PubMed ID: 481217
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer.
    Santamarina-Fojo S; Haudenschild C
    Int J Tissue React; 2000; 22(2-3):39-47. PubMed ID: 10937353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
    Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
    Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVALUATION of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis; report of a cooperative study of lipoproteins and atherosclerosis.
    Circulation; 1956 Oct; 14(4 Part 2):691-742. PubMed ID: 13374848
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteoglycans and potential mechanisms related to atherosclerosis.
    Berenson GS; Radhakrishnamurthy B; Srinivasan SR; Vijayagopal P; Dalferes ER
    Ann N Y Acad Sci; 1985; 454():69-78. PubMed ID: 3865616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.